Long-Term Evaluation of a Prolonged-Release Formulation of N-Methionyl Bovine Somatotropin in Lactating Dairy Cows

Authors:
  • DHDouglas L. Hard
    Douglas L. Hard
  • BCBrian A. Crooker
    Brian A. Crooker
  • MPMary S. Partridge
    Mary S. Partridge
  • KGKaren Garrick
    Karen Garrick
  • LSLeslie D. Sandles
    Leslie D. Sandles
  • HEHollis N. Erb
    Hollis N. Erb

Abstract
Eighty Holstein cows (first, second, or third lactation) were used to evaluate the efficacy of a prolonged-release formulation for sometribove (n-methionyl bovine somatotropin). Cows were fed ad libitum a complete mixed diet and milked twice daily. Cows were allocated randomly by parity to two treatment groups receiving 500 mg sometribove in a prolonged release formulation or excipient at 14-d intervals starting at 60 +/- 3 d postpartum and continuing for 36 wk. Treatment with sometribove increased FCM yield to a similar extent (11.4%, +3.1 kg/d) in primiparous and multiparous animals. Milk content of lactose, fat, ash, and Ca was not affected, but protein and phosphorous were slightly greater (less than 5%) in milk from sometribove-treated cows. Within a 14-d injection interval, animals treated with sometribove displayed a cyclic pattern in milk yield, but a similar pattern was not evident in feed intake.

This publication has 22 references indexed in Scilit: